Showing results (1841-1850 of 2,043) with videos related to
Sort By:
Pageof 205
Surgery|October 24, 2022
Impact of sarcopenia on the surgical outcomes in patients with hepatolithiasis: A multicenter 10-year experienceTingting Wang, Xinlei Chen, Chengyu Liao, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 21, 2025
SenExo-cCCT2 Reprograms Senescence Response and Anti-Tumor Immunity Following FOLFIRINOX Chemotherapy in Pancreatic Ductal AdenocarcinomaShuncang Zhu, Yinhao Chen, Hongyi Lin, et al.Oncology Letters|March 16, 2018
Glasgow Prognostic Score is superior to ECOG PS as a prognostic factor in patients with gastric cancer with peritoneal seedingShu-Qiang Yuan, Run-Cong Nie, Yong-Ming Chen, et al.Science Advances|May 23, 2024
Functional vertical connectivity of microbial communities in the oceanShi Chen, Zhang-Xian Xie, Ke-Qiang Yan, et al.Biomedical Journal|January 3, 2024
Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendationYung-Yeh Su, Nai-Jung Chiang, Tai-Jan Chiu, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 29, 2011
Evaluation of the mass measles vaccination campaign in Guangdong Province, ChinaZhi Qiang Peng, Wei Shi Chen, Qun He, et al.Japanese Journal of Clinical Oncology|December 19, 2022
Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062Hironaga Satake, Keun-Wook Lee, Hyun Cheol Chung, et al.Proceedings of the National Academy of Sciences of the United States of America|February 3, 2011
DNA phosphorothioation is widespread and quantized in bacterial genomesLianrong Wang, Shi Chen, Kevin L Vergin, et al.Annals of Surgical Oncology|December 24, 2022
Adjuvant Chemotherapy for Patients with Adenocarcinoma of the Esophagogastric Junction: A Retrospective, Multicenter, Observational StudyRun-Cong Nie, Tian-Qi Luo, Guo-Dong Li, et al.Acta Pharmaceutica Sinica. B|January 23, 2024
Structure-based development of potent and selective type-II kinase inhibitors of RIPK1Ying Qin, Dekang Li, Chunting Qi, et al.Pageof 205